Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 3, 2007, Pages 140-144

  McKie, Kathleen T ^a   Hanevold, Coral D ^a   Hernandez, Caterina ^a   Waller, Jennifer L ^a   Ortiz, Luis ^a   McKie, Kathleen M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

ACE inhibitor; Hydroxyurea; Microalbuminuria; Proteinuria; Sickle cell disease

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROXYUREA; LISINOPRIL;

ACIDOSIS; ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIZZINESS; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERKALEMIA; HYPOTENSION; KIDNEY DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEINURIA; SICKLE CELL ANEMIA; URINALYSIS;

ADOLESCENT; ADULT; AGE OF ONSET; ALBUMINURIA; ANEMIA, SICKLE CELL; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GEORGIA; HOMOZYGOTE; HUMANS; HYDROXYUREA; LONGITUDINAL STUDIES; MALE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROTEINURIA; TREATMENT OUTCOME;

EID: 34247583471     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3180335081     Document Type: Article

References (23)

1. Thomas AN, Pattison C, Serjeant GR. Causes of death in sickle cell disease in Jamaica. Br Med J Clin Res. 1982;285:633-635.
2. Steinberg MH. Management of sickle cell disease. N Engl J Med. 1999;340:1021-1030.
3. Wesson DE. The initiation and progression of sickle cell nephropathy. Kidney Int. 2002;61:2277-2286.
4. Powars DR, Elliott-Mills DD, Chan L, et al. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med. 1991;115:614-620.
5. Datta V, Ayengar JR, Karpate S, et al. Microalbuminuria as a predictor of early glomerular injury in children with sickle cell disease. Indian J Pediatr. 2003;70:307-309.
6. Guasch A, Cau M, Mitch WE. Early detection and the course of glomerular injury in patients with sickle cell anemia. Kidney Int. 1996;49:786-791.
7. Aoki RY, Saad STO. Enalapril reduces the albuminuria of patients with sickle cell disease. Am J Med. 1995;98:432-435.
8. Falk RJ, Scheinman J, Phillips G, et al. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med. 1992;326:910-915.
9. Foucan L, Bourhis V, Bangou J, et al. A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell disease. Am J Med. 1998;104:339-342.
10. Kinney TR, Helms RW, O'Branski EE, et al. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Blood. 1999;94:1550-1554.
11. Fitzhugh CD, Wigfall DR, Ware RE. Enalapril and hydroxyurea therapy for children with sickle nephropathy. Pediatr Blood Cancer. 2005;45:982-985.
12. Minetti EE, Cozzi MG, Granata S, et al. Accuracy of the urinary albumin titrator stick 'Micral-Test' in kidney disease patients. Nephrol Dial Transplant. 1997;12:78-90.
13. Shihabi ZK, Konen JC, O'Connor ML. Albuminuira vs. urinary total protein for detecting chronic renal disorders. Clin Chem. 1991;37:621-624.
14. Hogg RJ, Portman RJ, Milliner D, et al. Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics. 2000;105:1242-1249.
15. Hogg RJ, Furth S, Lemley KV, et al. National Kidney Foundation's kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics. 2003;111:1416-1421.
16. Wigfall DR, Ware RE, Burchinal MR, et al. Prevalence and clinical correlates of glomerulonephropathy in children with sickle cell disease. J Pediatr. 2000;136:149-153.
17. Aoki RY, Saad ST. Microalbuminuria in sickle cell disease. Braz J Med Biol Res. 1990;23:1103-1106.
18. Schmitt F, Martinez F, Brillet G, et al. Early glomerular dysfunction in patients with sickle cell anemia. Am J Kidney Dis. 1998;32:208-214.
19. Dharnidharka VR, Dabbagh S, Atiyeh B, et al. Prevalence of microalbuminuria in children with sickle cell disease. Pediatr-Nephrol. 1998;12:475-478.
20. McBurney PG, Hanevold CD, Hernandez CM, et al. Risk factors for microalbuminuria in children with sickle cell anemia. J Pediatr Hematol Oncol. 2002;24:473-477.
21. Hilgers KF, Dotsch J, Rascher W, et al. Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both? Pediatr Nephrol. 2004;19:959-961.
22. de Santis Feltran L, de Abren Carvalhaes JT, Sesso R. Renal complications of sickle cell disease: managing for optimal outcomes. Paediatr Drugs. 2002;4:29-35.
23. Bayazit AK, Noyan A, Aldudak B, et al. Renal function in children with sickle cell anemia. Clin Nephrol. 2002;57:127-130.